Physician

Anastasia Irene Wasylyshyn, MD

According to 2025 Medicare claims, Anastasia Wasylyshyn, MD (NPI: 1003263039) practices infectious disease in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1104858232; TIN: 386006309) and primary practice location at 48109-5000. Wasylyshyn is affiliated with the POM ACO (ACO ID: A1297) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Wasylyshyn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 142 traditional Medicare patients, billed 345 HCPCS/CPT codes, and received $28,079 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 543 prescription claims across 100 beneficiaries totaling $229,445 in drug costs, led by Triumeq (Abacavir/Dolutegravir/Lamivudi). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,493 to $229,445. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$41K2021 Medicare payment: $19,164 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $27,156 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $40,829 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $28,079 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202194245$19,164
2022137346$27,156
2023202493$40,829
2024142345$28,079

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$115K$229K2016 Drug cost: $5,493 (USD; Tot_Drug_Cst)2017 Drug cost: $6,690 (USD; Tot_Drug_Cst)2018 Drug cost: $532 (USD; Tot_Drug_Cst)2019 Drug cost: $11,342 (USD; Tot_Drug_Cst)2020 Drug cost: $33,146 (USD; Tot_Drug_Cst)2021 Drug cost: $72,033 (USD; Tot_Drug_Cst)2022 Drug cost: $160,249 (USD; Tot_Drug_Cst)2023 Drug cost: $206,401 (USD; Tot_Drug_Cst)2024 Drug cost: $229,445 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161442$5,493
20171850$6,690
20181839$532
20192459$11,342
20202381$33,146
202145194$72,033
202278354$160,249
202384430$206,401
2024100543$229,445

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes4649$135
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4983$95
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2424$94
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4361$70
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3238$58

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TriumeqAbacavir/Dolutegravir/Lamivudi23690$82,128
BiktarvyBictegrav/Emtricit/Tenofov Ala11330$41,715
MicafunginMicafungin Sodium1591$12,485
ErtapenemErtapenem Sodium26146$9,917
Ethambutol HclEthambutol Hcl301,385$2,749

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Anastasia Irene Wasylyshyn, MD?

Tedicare shows public-source Medicare data for Anastasia Irene Wasylyshyn, MD (NPI 1003263039), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anastasia Irene Wasylyshyn, MD have ACO affiliation data?

Anastasia Irene Wasylyshyn, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Anastasia Irene Wasylyshyn, MD?

Anastasia Irene Wasylyshyn, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1104858232) in the available physician profile data.

Does Anastasia Irene Wasylyshyn, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.